BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36762999)

  • 1. Characterization of Outpatient Gabapentinoid Prescribing for Pain.
    Banks C; A Bowman L; Merrey J; Waldfogel JM
    J Pain Palliat Care Pharmacother; 2023 Jun; 37(2):143-147. PubMed ID: 36762999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Gabapentin and Pregabalin Prescribing in a Tertiary Pediatric Medical Center.
    Donado C; Nedeljkovic K; Wangnamthip S; Solodiuk JC; Bourgeois FT; Berde CB
    Hosp Pediatr; 2021 Aug; 11(8):909-914. PubMed ID: 34257145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Effectiveness of Gabapentin and Pregabalin in Treatment of Neuropathic Pain: A Retrospective Cohort of Palliative Care Outpatients.
    Dragic L; Webb T; Chandler M; Harrington SB; McDade E; Dayer L; Painter JT
    J Pain Palliat Care Pharmacother; 2020 Dec; 34(4):192-196. PubMed ID: 32924715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Clinical Overview of Off-label Use of Gabapentinoid Drugs.
    Goodman CW; Brett AS
    JAMA Intern Med; 2019 May; 179(5):695-701. PubMed ID: 30907944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Series: Synergistic Effect of Gabapentin and Adjuvant Pregabalin in Neuropathic Pain.
    Chow SP; Stevens S; Tran S; Donelenko S
    J Pain Palliat Care Pharmacother; 2023 Mar; 37(1):106-109. PubMed ID: 36512682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review.
    Kaul I; Amin A; Rosenberg M; Rosenberg L; Meyer WJ
    Burns; 2018 Mar; 44(2):414-422. PubMed ID: 28822592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy.
    Pan Y; Davis PB; Kaebler DC; Blankfield RP; Xu R
    Cardiovasc Diabetol; 2022 Sep; 21(1):170. PubMed ID: 36050764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy.
    Udall M; Harnett J; Mardekian J
    J Med Econ; 2012; 15(2):361-70. PubMed ID: 22181052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
    Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
    Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
    Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
    Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients.
    Ruessmann HJ;
    J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.
    Gore M; Tai KS; Zlateva G; Bala Chandran A; Leslie D
    Pain Pract; 2011; 11(6):528-39. PubMed ID: 21435162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentinoid Dosing and Associated Toxicities in Patients With or Without Concomitant Opioids During Hospitalization.
    Tu TG; Sadeghi S; Atayee R; Lee K
    Am J Hosp Palliat Care; 2022 May; 39(5):530-534. PubMed ID: 34409886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative myoclonus induced by gabapentin and pregabalin: A case series and systematic literature review.
    Kim JB; Jung JM; Park MH; Lee EJ; Kwon DY
    J Neurol Sci; 2017 Nov; 382():36-39. PubMed ID: 29111014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Gabapentin and Pregabalin Use in Hospitalized Patients With Decreased Kidney Function.
    Knowles GM; LaFleur GE; Churchwell MD
    J Pharm Technol; 2024 Feb; 40(1):30-36. PubMed ID: 38318261
    [No Abstract]   [Full Text] [Related]  

  • 17. A Retrospective Analysis of Gabapentinoid and Opioids to Opioid Monotherapy for Pain Relief in Patients with Chronic Neck and Low Back Pain.
    Knezevic NN; Aijaz T; Camacho-Ortega A; Candido KD
    Pain Med; 2021 Aug; 22(8):1760-1766. PubMed ID: 33502505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study.
    Pérez C; Navarro A; Saldaña MT; Masramón X; Rejas J
    Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity.
    Sicras-Mainar A; Rejas-Gutiérrez J; Pérez-Páramo M; Navarro-Artieda R
    J Eval Clin Pract; 2017 Apr; 23(2):402-412. PubMed ID: 27671223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of the preoperative use of gabapentinoids for the treatment of acute postoperative pain following spinal surgery.
    Liu B; Liu R; Wang L
    Medicine (Baltimore); 2017 Sep; 96(37):e8031. PubMed ID: 28906391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.